NCT00244543View on ClinicalTrials.gov

Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2005

Conditions
Allergic Conjunctivitis
Interventions
DRUG

R89674 (generic name not yet established)

Trial Locations (1)

Unknown

North Andover

All Listed Sponsors
lead

Vistakon Pharmaceuticals

INDUSTRY

NCT00244543 - Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis | Biotech Hunter | Biotech Hunter